How can I simplify a basal insulin regimen of insulin glargine (Lantus) 76 units at 8 am and 25 units at 8 pm into a single daily dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Simplifying Split-Dose Lantus to Once-Daily Dosing

Convert your current total daily dose of 101 units (76 + 25 units) to approximately 80-85 units of Lantus given once daily, preferably in the morning or evening based on your glucose patterns, with close glucose monitoring for the first 2-3 weeks.

Conversion Strategy

The FDA label for Lantus specifically addresses this exact scenario 1. When converting from twice-daily NPH or split-dose basal insulin to once-daily Lantus, start with 80% of the total daily basal dose to reduce hypoglycemia risk 1.

Calculation:

  • Current total daily dose: 76 + 25 = 101 units
  • Initial once-daily Lantus dose: 101 × 0.80 = 80-81 units

Start with 80 units once daily and titrate up by 2 units every 3 days based on fasting glucose readings 2.

Timing Considerations

Lantus can be administered at any time of day, but must be at the same time every day 1. Given your current split:

  • Morning dosing (8 AM) may be preferable since your larger dose (76 units) is already at this time
  • Evening dosing (8-10 PM) is also appropriate if nocturnal glucose control is problematic
  • Research shows bedtime dosing can cause early-night hyperglycemia, which improves with morning or dinner-time administration 3

Choose the time that best fits your schedule and when you're most likely to remember consistently 1.

Monitoring and Titration

Critical First 2-3 Weeks:

  • Check fasting glucose daily to guide dose adjustments 2
  • Monitor for hypoglycemia, especially nocturnal hypoglycemia 1
  • If hypoglycemia occurs without clear cause, reduce dose by 10-20% 2

Dose Adjustment Algorithm 2:

  • Increase by 2 units every 3 days until fasting glucose reaches target
  • If A1C <8% at baseline, consider starting at 70-75 units (reduce by 10% more) 2
  • Maximum adjustments should be made under medical supervision 1

Important Safety Considerations

Hypoglycemia Risk:

The 20% dose reduction when converting is specifically designed to lower hypoglycemia risk during the transition 1. The evidence consistently shows Lantus has reduced nocturnal hypoglycemia compared to NPH 4, 5, but the transition period requires vigilance.

What NOT to Do:

  • Never mix Lantus with other insulins in the same syringe 1
  • Never administer intravenously 1
  • Do not use in insulin pumps 1
  • Do not dilute 1

Why This Simplification Works

Lantus (insulin glargine) has a relatively constant 24-hour glucose-lowering profile without pronounced peaks 1, 4, 5, making once-daily dosing physiologically appropriate. Your current split-dosing pattern suggests you may have been experiencing either:

  • Inadequate overnight coverage (hence the evening dose)
  • Dawn phenomenon requiring the large morning dose

Once-daily Lantus at 80% of your total dose should provide more stable basal coverage 4, 5.

If Glycemic Control Remains Suboptimal

After 2-3 weeks of titration, if A1C remains above goal 2:

  • Consider adding a GLP-1 receptor agonist (if type 2 diabetes and not already on one)
  • Evaluate for "overbasalization" signs: high glucose variability, postprandial spikes
  • May need to add prandial (mealtime) insulin if basal insulin alone is insufficient 2

The key is that Lantus is designed for once-daily dosing—your split-dose regimen is unnecessarily complex and can be safely consolidated 1, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.